Navigation Links
HeartSine® Increases AED System Warranty to Longest in the Industry
Date:5/31/2011

NEWTOWN, Pa., May 31, 2011 /PRNewswire/ -- HeartSine Technologies, Inc, a world leader in personal and public access defibrillators, has increased its system warranty period to an exclusive 10 years on its popular HeartSine® samaritan® PAD 300P Public Access Defibrillator (PAD) for the treatment of Sudden Cardiac Arrest. The samaritan PAD currently is the fastest growing AED. The life of its Pad-Pak® device, a battery and electrode contained in an integrated cartridge has also been increased to four years. Both the life of the Pad-Pak and the samaritan PAD's product warranty are the longest available in the Automated External Defibrillator (AED) industry.

HeartSine's commitment to innovation and significant investments in research and development have resulted in industry advanced technology, firmware, software and components which meet and exceed AED clinical efficacy standards. This Innovation enables HeartSine to provide end users with exceptional product reliability and the lowest cost of ownership.

"At HeartSine, our passion is to continue to design and develop compact, easy-to-use and extremely reliable AED devices to customers where our superior lifesaving technology helps save the lives of colleagues, customers and friends," said Marc Lawrence, HeartSine senior vice president. "Our 10-year warranty and 4-year Pad-Pak life has helped make the best life saving device even better."

About HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the development of proprietary technologies and quality products. The HeartSine® samaritan® PAD Public Access Defibrillator is a medical device especially designed for public access use, to administer lifesaving treatment for Sudden Cardiac Arrest. It is a sophisticated, lightweight Automated External Defibrillator designed for rescuers of all skill levels and is ideal for sports facilities, schools, churches and all businesses.

For more information, please contact info@heartsine.com, call (866) 478-7463, ext. 112, or visit www.heartsine.com.

Contact: Marc Lawrence
Phone: 215.860.8100
marc.lawrence@heartsine.com


'/>"/>
SOURCE HeartSine Technologies, Inc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
2. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
3. Demand for VScan Dengue Fever Test Kits Increases
4. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
5. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
6. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
7. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
8. New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
9. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
10. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
11. New Pharma Business Model Increases Pressure on Staff Communicating Trial Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology:
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):